Sterculia diversifolia bears anti-cancer and immunomodulatory activities

Authors

  • Fazle Rabbi Department of Pharmacy, University of Peshawar, Peshawar
  • Amir Zada Department of Pharmacy, University of Peshawar, Peshawar
  • Achyut Adhikari HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi http://orcid.org/0000-0002-1065-5727
  • Almas Jabeen Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi http://orcid.org/0000-0002-6043-9539
  • Amna Nisar Department of Pharmacy, University of Peshawar, Peshawar
  • Irfan Ullah Department of Pharmacy, Abasyn University, Peshawar http://orcid.org/0000-0001-5718-1162

DOI:

https://doi.org/10.3329/bjp.v12i1.29516

Keywords:

Anti-cancer, Immunomodulatory, Sterculia diversifolia

Abstract

The present study was aimed to evaluate the methanolic extract and subsequent solvents soluble fractions of Sterculia diversifolia bark for cytotoxic, anti-cancer and immunomodulatory activities. Phytochemical investigation confirmed the presence of alkaloids, flavonoids, saponins, glycosides, etc. In the cytotoxic activity, n-hexane showed potent activity (LD50: 7.0 µg/mL) followed by dichloromethane fraction (LD50: 16.2 µg/mL). In the anti-cancer activity, dichloromethane fraction showed potent activity (IC50: 5.9 µg/mL) followed by ethyl acetate fraction (IC50: 9.5 µg/mL). While in the immunomodulatory assay, ethyl acetate fraction showed a very significant activity (IC50: 21.0 µg/mL) followed by dicloromethane and n-butanol fractions (IC50: 25.0 and 25.3 µg/mL respectively). Hence, it is clear that S. diversifolia has anti-cancer and immunomodulatory agents.

Video Clip of Methodology:

ROS Assay: 2 min 9 sec   Full Screen   Alternate

Downloads

Download data is not yet available.
Abstract
4
Download
5 Read
2

Author Biography

Achyut Adhikari, HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi

Assistant Professor

Downloads

Additional Files

Published

2017-03-03

How to Cite

Rabbi, F., A. Zada, A. Adhikari, A. Jabeen, A. Nisar, and I. Ullah. “Sterculia Diversifolia Bears Anti-Cancer and Immunomodulatory Activities”. Bangladesh Journal of Pharmacology, vol. 12, no. 1, Mar. 2017, pp. 51-55, doi:10.3329/bjp.v12i1.29516.

Issue

Vol. 12 No. 1 (2017)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).